{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Tyra Biosciences, Inc.
Is Tyra Biosciences, Inc. technically bullish or bearish?
As of June 2, 2025, the technical trend is mildly bearish, with daily moving averages and weekly Bollinger Bands indicating bearish sentiment, while mixed signals from the MACD and KST suggest caution with slight underlying strength.
What does Tyra Biosciences, Inc. do?
Tyra Biosciences, Inc. is a micro-cap company in the miscellaneous industry, currently reporting a net profit loss of $28 million and a market cap of $509.98 million. Key financial metrics include a negative P/E ratio, a 0.00% dividend yield, and a debt-to-equity ratio of -0.98.
How big is Tyra Biosciences, Inc.?
As of Jun 18, Tyra Biosciences, Inc. has a market capitalization of 509.98 million and reported net sales of 0.00 million with a net profit of -96.44 million for the latest four quarters. The balance sheet shows shareholder's funds of 343.15 million and total assets of 365.10 million.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
